Serina Therapeutics (SER) Cash from Investing Activities (2018 - 2025)
Serina Therapeutics (SER) posted Cash from Investing Activities of -$13000.0 for Q3 2025, up 71.74% sequentially from -$46000.0 in Q2 2025, and down 333.33% YoY from $5571.4 in Q3 2024.
Serina Therapeutics (SER) Cash from Investing Activities (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Cash from Investing Activities for 7 years, with the latest figure at -$13000.0 in Q3 2025.
- Quarterly Cash from Investing Activities fell 333.33% year-over-year to -$13000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$59000.0 (down 168.18% YoY) and the FY2025 annual result came in at -$59000.0, down 168.18% from the prior year.
- Cash from Investing Activities improved to -$13000.0 in Q3 2025 per SER's latest filing, from -$46000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $9.7 million in Q2 2023 and troughed at -$10.0 million in Q1 2023.
- A 4-year average of $6230.8 and a median of -$13000.0 in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2021 and 2025: Cash from Investing Activities soared 11750.0% in 2021, then plunged 333.33% in 2025.
- Over 4 years, Cash from Investing Activities stood at -$50000.0 in 2021, then sank by 40.0% to -$70000.0 in 2023, then surged by 92.86% to -$5000.0 in 2024, then plunged by 160.0% to -$13000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$13000.0, -$46000.0, and -$5000.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -46,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -70,000.00 |
| Dec 31, 2023 | -70,000.00 |
| Sep 30, 2023 | -119,000.00 |
| Sep 30, 2023 | -119,000.00 |
| Jun 30, 2023 | 9.69 Mn |
| Jun 30, 2023 | 9.69 Mn |
| Mar 31, 2023 | -10.00 Mn |
| Mar 31, 2023 | -10.00 Mn |
| Dec 31, 2021 | -50,000.00 |
| Dec 31, 2021 | -50,000.00 |